Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: Involvement of antioxidative enzymes induction

被引:86
|
作者
Wu, Chi-Rei [1 ]
Tsai, Chia-Wen [2 ]
Chang, Shu-Wei [3 ]
Lin, Chia-Yuan [2 ]
Huang, Li-Chun [2 ]
Tsai, Chia-Wen [2 ]
机构
[1] China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan
[2] China Med Univ, Dept Nutr, Taichung, Taiwan
[3] Dayeh Univ, Dept Med Bot & Hlth Care, Changhua, Taiwan
关键词
Carnosic acid; Neuroprotection; Antioxidative enzymes; Apoptosis; Wistar rats; GLUTATHIONE METABOLISM; PC12; CELLS; OXIDATIVE STRESS; SH-SY5Y CELLS; APOPTOSIS; 6-OHDA; ACTIVATION; DEATH; CONSTITUENTS; BCL-2/BAX;
D O I
10.1016/j.cbi.2014.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuroprotective effects of carnosic acid (CA), a phenolic diterpene isolated from rosemary (Rosmarinus officinalis), have been widely investigated in recent years, however, its protection in in vivo still unclear. In this study, we investigated the behavioral activity and neuroprotective effects of CA in a rat model of Parkinson's disease (PD) induced by 6-hydroxydopamine (6-OHDA). Rats were treated with 20 mg/kg body weight of CA for 3 weeks before 6-OHDA exposure. Results indicated that CA improved the locomotor activity and reduced the apomorphine-caused rotation in 6-OHDA-stimulated rats. Significant protection against lipid peroxidation and GSH reduction was observed in the 6-OHDA rats pre-treated with CA. Pretreatment with CA increased the protein expression of gamma-glutamate-cysteine ligase catalytic subunit, gamma-glutamate-cysteine ligase modifier subunit, superoxide dismutase, and glutathione reductase compared with 6-OHDA-stimulated rats and SH-SY5Y cells. Immunoblots showed that the reduction of the Bcl-2/Bax ratio, the induction of caspase 3 cleavage, and the induction of poly(ADPribose) polymerase (PARP) cleavage by 6-OHDA was reversed in the presence of SB203580 (a p38 inhibitor) or SP600125 (a JNK inhibitor) in SH-SY5Y cells. Rats treated with CA reversed the 6-OHDA-mediated the activation of c-JunNH2-terminal kinase and p38, the down-regulation of the Bcl-2/Bax ratio, the up-regulation of cleaved caspase 3/caspase 3 and cleaved PARP/PARP ratio, and the down-regulation of tyrosine hydroxylase protein. However, BAM7, an activator of Bax, attenuated the effect of CA on apoptosis in SH-SY5Y cells. These results suggest that CA protected against 6-OHDA-induced neurotoxicity is attributable to its anti-apoptotic and anti-oxidative action. The present findings may help to clarify the possible mechanisms of rosemary in the neuroprotection of PD. (C) 2014 Published by Elsevier Ireland Ltd.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [21] Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity:: relevance for Parkinson's disease
    Soto-Otero, R
    Méndez-Alvarez, E
    Hermida-Ameijeiras, A
    López-Real, AM
    Labandeira-García, JL
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (01) : 125 - 135
  • [22] Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson's Disease
    Farbood, Yaghoob
    Sarkaki, Alireza
    Dolatshahi, Mojtaba
    Mansouri, Seyed Mohammad Taqhi
    Khodadadi, Ali
    BASIC AND CLINICAL NEUROSCIENCE, 2015, 6 (02) : 83 - 90
  • [23] Effectiveness of Albumin-Fused Thioredoxin against 6-Hydroxydopamine-Induced Neurotoxicity In Vitro
    Sakakibara, Okina
    Shimoda, Mikako
    Yamamoto, Gaku
    Higashi, Youichirou
    Ikeda-Imafuku, Mayumi
    Ishima, Yu
    Kawahara, Masahiro
    Tanaka, Ken-ichiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [24] Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
    Fu, Yuan
    Ito, Mikako
    Fujita, Yasunori
    Ito, Masafumi
    Ichihara, Masatoshi
    Masuda, Akio
    Suzuki, Yumi
    Maesawa, Satoshi
    Kajita, Yasukazu
    Hirayama, Masaaki
    Ohsawa, Ikuroh
    Ohta, Shigeo
    Ohno, Kinji
    NEUROSCIENCE LETTERS, 2009, 453 (02) : 81 - 85
  • [25] The Effect of Glutathione Isopropyl Ester on 6-Hydroxydopamine-induced Model of Parkinson's Disease
    Ozsoy, Ozlem
    Aslan, Mutay
    Tanriover, Gamze
    Yuruker, Sinan
    Demir, Necdet
    Agar, Aysel
    ACTA PHYSIOLOGICA, 2016, 218 : 70 - 71
  • [26] Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease
    Kopalli, Spandana Rajendra
    Noh, Su-Jin
    Koppula, Sushruta
    Suh, Yoo-Hun
    NEUROTOXICOLOGY, 2013, 34 : 25 - 32
  • [27] Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins
    Goes, Andre T. R.
    Jesse, Cristiano R.
    Antunes, Michelle S.
    Lobo Ladd, Fernando V.
    Lobo Ladd, Aliny A. B.
    Luchese, Cristiane
    Paroul, Natalia
    Boeira, Silvana P.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 279 : 111 - 120
  • [28] A Glimpse into the Genome-wide DNA Methylation Changes in 6-hydroxydopamine-induced In Vitro Model of Parkinson's Disease
    Magalingam, Kasthuri Bai
    Somanath, Sushela Devi
    Radhakrishnan, Ammu Kutty
    EXPERIMENTAL NEUROBIOLOGY, 2023, 32 (03) : 119 - 132
  • [29] Acetyl-L-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat
    Afshin-Majd, Siamak
    Bashiri, Keyhan
    Kiasalari, Zahra
    Baluchnejadmojarad, Tourandokht
    Sedaghat, Reza
    Roghani, Mehrdad
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 1 - 9
  • [30] Sinapic Acid Protects SH-SY5Y Human Neuroblastoma Cells against 6-Hydroxydopamine-Induced Neurotoxicity
    Tungalag, Tsendsuren
    Yang, Dong Kwon
    BIOMEDICINES, 2021, 9 (03)